

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * protein neddylation (GO:0045116) | 5.01249171 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.97017482 |
| 3 | response to peptidoglycan (GO:0032494) | 4.89495911 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54601913 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 4.19188437 |
| 6 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.14283234 |
| 7 | DNA deamination (GO:0045006) | 4.09145517 |
| 8 | regulation of chemokine biosynthetic process (GO:0045073) | 4.08658845 |
| 9 | thrombin receptor signaling pathway (GO:0070493) | 4.00469014 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.00412214 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 3.96528825 |
| 12 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.86905536 |
| 13 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.85593269 |
| 14 | natural killer cell mediated immunity (GO:0002228) | 3.85593269 |
| 15 | reactive oxygen species biosynthetic process (GO:1903409) | 3.81867834 |
| 16 | regulation of fever generation (GO:0031620) | 3.77593332 |
| 17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.75836901 |
| 18 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.73089409 |
| 19 | granulocyte activation (GO:0036230) | 3.71048181 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.66981887 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.64593273 |
| 22 | positive regulation of heat generation (GO:0031652) | 3.58991469 |
| 23 | neutrophil activation (GO:0042119) | 3.58550143 |
| 24 | cytidine metabolic process (GO:0046087) | 3.57751792 |
| 25 | cytidine catabolic process (GO:0006216) | 3.57751792 |
| 26 | cytidine deamination (GO:0009972) | 3.57751792 |
| 27 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.54080901 |
| 28 | superoxide anion generation (GO:0042554) | 3.52111730 |
| 29 | cellular response to interferon-beta (GO:0035458) | 3.52043285 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50686981 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50686981 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 3.50686981 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50686981 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.50686981 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50686981 |
| 36 | respiratory burst (GO:0045730) | 3.49456947 |
| 37 | regulation of activation of Janus kinase activity (GO:0010533) | 3.45456048 |
| 38 | platelet dense granule organization (GO:0060155) | 3.44942112 |
| 39 | response to interferon-beta (GO:0035456) | 3.29929108 |
| 40 | actin nucleation (GO:0045010) | 3.29214376 |
| 41 | myeloid dendritic cell differentiation (GO:0043011) | 3.28914962 |
| 42 | defense response to protozoan (GO:0042832) | 3.26939655 |
| 43 | neutrophil mediated immunity (GO:0002446) | 3.25149754 |
| 44 | leukocyte mediated cytotoxicity (GO:0001909) | 3.22684567 |
| 45 | myeloid leukocyte mediated immunity (GO:0002444) | 3.22256213 |
| 46 | positive regulation of interleukin-12 production (GO:0032735) | 3.22106986 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.21435972 |
| 48 | myeloid dendritic cell activation (GO:0001773) | 3.18115100 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.18051802 |
| 50 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.16597663 |
| 51 | leukocyte degranulation (GO:0043299) | 3.14362433 |
| 52 | regulation of platelet activation (GO:0010543) | 3.13685266 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.12672961 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.12672961 |
| 55 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.11792542 |
| 56 | negative regulation of viral genome replication (GO:0045071) | 3.11706964 |
| 57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.10537227 |
| 58 | regulation of chronic inflammatory response (GO:0002676) | 3.09340852 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.08939740 |
| 60 | cellular response to exogenous dsRNA (GO:0071360) | 3.08765280 |
| 61 | response to type I interferon (GO:0034340) | 3.06693277 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 3.04127953 |
| 63 | negative regulation of interleukin-17 production (GO:0032700) | 3.03606397 |
| 64 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.02893444 |
| 65 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.02266328 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.00980368 |
| 67 | B cell mediated immunity (GO:0019724) | 3.00286219 |
| 68 | negative regulation of growth of symbiont in host (GO:0044130) | 2.99352694 |
| 69 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.99352694 |
| 70 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.99352694 |
| 71 | regulation of growth of symbiont in host (GO:0044126) | 2.99352694 |
| 72 | positive regulation of macrophage differentiation (GO:0045651) | 2.99035914 |
| 73 | proteasome assembly (GO:0043248) | 2.98298427 |
| 74 | cellular response to zinc ion (GO:0071294) | 2.97974750 |
| 75 | autophagic vacuole fusion (GO:0000046) | 2.97791364 |
| 76 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.96857518 |
| 77 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95293571 |
| 78 | regulation of RIG-I signaling pathway (GO:0039535) | 2.95087039 |
| 79 | lipoxygenase pathway (GO:0019372) | 2.94549497 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 2.93268966 |
| 81 | response to protozoan (GO:0001562) | 2.92255123 |
| 82 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.91893535 |
| 83 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.89752984 |
| 84 | monocyte chemotaxis (GO:0002548) | 2.88493645 |
| 85 | signal peptide processing (GO:0006465) | 2.87841153 |
| 86 | positive regulation of interferon-beta production (GO:0032728) | 2.87678499 |
| 87 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.86989768 |
| 88 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.86873593 |
| 89 | mitochondrial calcium ion transport (GO:0006851) | 2.85974347 |
| 90 | negative regulation of T cell apoptotic process (GO:0070233) | 2.85683025 |
| 91 | macrophage activation involved in immune response (GO:0002281) | 2.82766739 |
| 92 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.81648048 |
| 93 | regulation of platelet aggregation (GO:0090330) | 2.81266725 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81015635 |
| 95 | negative regulation of cell killing (GO:0031342) | 2.81015635 |
| 96 | positive regulation of interleukin-17 production (GO:0032740) | 2.80680627 |
| 97 | purine-containing compound salvage (GO:0043101) | 2.76878017 |
| 98 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74634586 |
| 99 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.74289709 |
| 100 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.74250241 |
| 101 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.72913095 |
| 102 | regulation of interleukin-12 production (GO:0032655) | 2.72066033 |
| 103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72056967 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.71857830 |
| 105 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.71697199 |
| 106 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.71614075 |
| 107 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.70987036 |
| 108 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.70601488 |
| 109 | leukocyte aggregation (GO:0070486) | 2.70126334 |
| 110 | eosinophil chemotaxis (GO:0048245) | 2.68727476 |
| 111 | regulation of immunoglobulin secretion (GO:0051023) | 2.68521083 |
| 112 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.66560588 |
| 113 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.66197984 |
| 114 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.66059056 |
| 115 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.65980667 |
| 116 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65848535 |
| 117 | response to host immune response (GO:0052572) | 2.65848535 |
| 118 | response to interferon-alpha (GO:0035455) | 2.65727559 |
| 119 | positive regulation of B cell differentiation (GO:0045579) | 2.65624331 |
| 120 | organelle membrane fusion (GO:0090174) | 2.65377103 |
| 121 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.64527489 |
| 122 | sequestering of actin monomers (GO:0042989) | 2.63233736 |
| 123 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.62745789 |
| 124 | regulation of heat generation (GO:0031650) | 2.62200436 |
| 125 | polyamine biosynthetic process (GO:0006596) | 2.62197583 |
| 126 | cellular response to virus (GO:0098586) | 2.61180136 |
| 127 | T-helper 1 type immune response (GO:0042088) | 2.60580865 |
| 128 | eosinophil migration (GO:0072677) | 2.60438661 |
| 129 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.60410578 |
| 130 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60058453 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59702398 |
| 132 | positive regulation of DNA recombination (GO:0045911) | 2.58990556 |
| 133 | negative regulation of heart rate (GO:0010459) | 2.58881861 |
| 134 | detection of molecule of bacterial origin (GO:0032490) | 2.57551031 |
| 135 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.57109153 |
| 136 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.57109153 |
| 137 | regulation of mononuclear cell migration (GO:0071675) | 2.56704344 |
| 138 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56554545 |
| 139 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.56331953 |
| 140 | positive regulation of type 2 immune response (GO:0002830) | 2.56005013 |
| 141 | positive regulation of humoral immune response (GO:0002922) | 2.55610448 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.54831937 |
| 143 | regulation of interleukin-17 production (GO:0032660) | 2.54620790 |
| 144 | negative regulation of interleukin-12 production (GO:0032695) | 2.54336150 |
| 145 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.54293682 |
| 146 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.54293682 |
| 147 | negative regulation of mast cell activation (GO:0033004) | 2.54011720 |
| 148 | adenosine receptor signaling pathway (GO:0001973) | 2.53525168 |
| 149 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.53054462 |
| 150 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.48995290 |
| 151 | natural killer cell activation involved in immune response (GO:0002323) | 2.47104473 |
| 152 | positive regulation of interleukin-10 production (GO:0032733) | 2.46963113 |
| 153 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.46641636 |
| 154 | positive regulation of B cell mediated immunity (GO:0002714) | 2.46569179 |
| 155 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.46569179 |
| 156 | mast cell activation (GO:0045576) | 2.44652271 |
| 157 | positive regulation of isotype switching (GO:0045830) | 2.44169789 |
| 158 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.43372004 |
| 159 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.40096320 |
| 160 | interferon-gamma production (GO:0032609) | 2.39725344 |
| 161 | adenosine metabolic process (GO:0046085) | 2.39065589 |
| 162 | cellular response to interleukin-15 (GO:0071350) | 2.38395803 |
| 163 | purinergic receptor signaling pathway (GO:0035587) | 2.37903488 |
| 164 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37827759 |
| 165 | deoxyribonucleotide catabolic process (GO:0009264) | 2.37443261 |
| 166 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.33425856 |
| 167 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.29203820 |
| 168 | purine nucleotide salvage (GO:0032261) | 2.28792903 |
| 169 | regulation of gamma-delta T cell activation (GO:0046643) | 2.28143000 |
| 170 | phagosome maturation (GO:0090382) | 2.27652070 |
| 171 | regulation of mast cell degranulation (GO:0043304) | 2.27044697 |
| 172 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.26334071 |
| 173 | adaptation of signaling pathway (GO:0023058) | 2.25869234 |
| 174 | deoxyribose phosphate catabolic process (GO:0046386) | 2.25356436 |
| 175 | positive regulation of lymphocyte migration (GO:2000403) | 2.24848133 |
| 176 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.23026517 |
| 177 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.22634660 |
| 178 | regulation of T cell tolerance induction (GO:0002664) | 2.22542942 |
| 179 | response to interleukin-15 (GO:0070672) | 2.22217739 |
| 180 | platelet aggregation (GO:0070527) | 2.22024714 |
| 181 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.21707092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.96229500 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.56690999 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.22920779 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.12014128 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.25476395 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.05480573 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.99425447 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83441698 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68037138 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60444190 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59056921 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58492488 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.58374748 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50038354 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49508388 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38434367 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.31574588 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.21958532 |
| 19 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19805205 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.18041674 |
| 21 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15094736 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.11622587 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07738401 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01505385 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98548812 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93442196 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.92334514 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.87862536 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87822636 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78749468 |
| 31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.78336948 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78045644 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75068752 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.73238412 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70411671 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.67136907 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66656215 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63524235 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62578810 |
| 40 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57348745 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54591955 |
| 42 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52951938 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.52843754 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52809120 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50111459 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49115507 |
| 47 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43791495 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.42887662 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41367140 |
| 50 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41210359 |
| 51 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40165374 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39475383 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37918464 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37195630 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37131680 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36782864 |
| 57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35965412 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34841057 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34801511 |
| 60 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33854689 |
| 61 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33504555 |
| 62 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.29918067 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29810511 |
| 64 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29337404 |
| 65 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28492882 |
| 66 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28133900 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27824799 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27470019 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27319451 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27296189 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27249744 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25533067 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21689002 |
| 74 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.21098715 |
| 75 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18571200 |
| 76 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18258853 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17562602 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15509947 |
| 79 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15508804 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14372947 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14003373 |
| 82 | MYB_26560356_Chip-Seq_TH1_Human | 1.13091173 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12789671 |
| 84 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12195615 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11796604 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11513507 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10194313 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09555339 |
| 89 | * MAF_26560356_Chip-Seq_TH1_Human | 1.07097361 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05222659 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05174915 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04673399 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04211061 |
| 94 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02788564 |
| 95 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.01038900 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00539599 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00428836 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99875007 |
| 99 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99770569 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99551753 |
| 101 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99278673 |
| 102 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.98238121 |
| 103 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98077218 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96568584 |
| 105 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96040114 |
| 106 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95789223 |
| 107 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95604021 |
| 108 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95159129 |
| 109 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94819436 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94559345 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94232787 |
| 112 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94028615 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94007803 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93989933 |
| 115 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93040166 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92848641 |
| 117 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92694684 |
| 118 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92017583 |
| 119 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.91656477 |
| 120 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.90965732 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90922141 |
| 122 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90852112 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89528943 |
| 124 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89479806 |
| 125 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89177758 |
| 126 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88319776 |
| 127 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.88026650 |
| 128 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87489410 |
| 129 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87320229 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86436352 |
| 131 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.85260383 |
| 132 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84916604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.85800744 |
| 2 | MP0009785_altered_susceptibility_to | 4.26184240 |
| 3 | MP0003436_decreased_susceptibility_to | 3.60289996 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.48835368 |
| 5 | MP0005671_abnormal_response_to | 3.31705664 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.91953657 |
| 7 | MP0005025_abnormal_response_to | 2.88286970 |
| 8 | MP0002419_abnormal_innate_immunity | 2.87431677 |
| 9 | MP0006082_CNS_inflammation | 2.87175756 |
| 10 | MP0000685_abnormal_immune_system | 2.77361953 |
| 11 | MP0008004_abnormal_stomach_pH | 2.67338082 |
| 12 | MP0003724_increased_susceptibility_to | 2.63033242 |
| 13 | MP0003186_abnormal_redox_activity | 2.43608793 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.40121523 |
| 15 | MP0001853_heart_inflammation | 2.37167040 |
| 16 | MP0001790_abnormal_immune_system | 2.33479385 |
| 17 | MP0005387_immune_system_phenotype | 2.33479385 |
| 18 | MP0002723_abnormal_immune_serum | 2.32596947 |
| 19 | MP0001800_abnormal_humoral_immune | 2.17408160 |
| 20 | MP0001819_abnormal_immune_cell | 2.12577368 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.07687392 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.04048894 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.98824776 |
| 24 | MP0009764_decreased_sensitivity_to | 1.97971749 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.85648252 |
| 26 | MP0003303_peritoneal_inflammation | 1.84784016 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.84686806 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.84550737 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.83014715 |
| 30 | MP0008469_abnormal_protein_level | 1.82113911 |
| 31 | MP0005083_abnormal_biliary_tract | 1.80352321 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.78388583 |
| 33 | MP0002006_tumorigenesis | 1.66990221 |
| 34 | MP0004510_myositis | 1.64712175 |
| 35 | MP0002405_respiratory_system_inflammati | 1.64626087 |
| 36 | MP0003646_muscle_fatigue | 1.61637095 |
| 37 | MP0000858_altered_metastatic_potential | 1.60917681 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.59557402 |
| 39 | MP0000343_altered_response_to | 1.57802934 |
| 40 | MP0004947_skin_inflammation | 1.56197293 |
| 41 | MP0002398_abnormal_bone_marrow | 1.51543845 |
| 42 | MP0000716_abnormal_immune_system | 1.51247045 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.48377781 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.44941665 |
| 45 | MP0003448_altered_tumor_morphology | 1.42480646 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.42000419 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.42000419 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.40362931 |
| 49 | MP0006054_spinal_hemorrhage | 1.37080041 |
| 50 | MP0002429_abnormal_blood_cell | 1.30307503 |
| 51 | MP0005410_abnormal_fertilization | 1.27662222 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.26544778 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.23527784 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.19121771 |
| 55 | MP0003866_abnormal_defecation | 1.17854800 |
| 56 | MP0002722_abnormal_immune_system | 1.15227652 |
| 57 | MP0003195_calcinosis | 1.15096914 |
| 58 | MP0000230_abnormal_systemic_arterial | 1.14311577 |
| 59 | MP0002736_abnormal_nociception_after | 1.14099381 |
| 60 | MP0009763_increased_sensitivity_to | 1.10819677 |
| 61 | MP0003075_altered_response_to | 1.10180809 |
| 62 | MP0004147_increased_porphyrin_level | 1.08469920 |
| 63 | MP0002163_abnormal_gland_morphology | 1.08305652 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.07887493 |
| 65 | MP0008260_abnormal_autophagy | 1.06351365 |
| 66 | MP0004084_abnormal_cardiac_muscle | 1.04926723 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.03827326 |
| 68 | MP0004036_abnormal_muscle_relaxation | 1.03564802 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.03528205 |
| 70 | MP0000372_irregular_coat_pigmentation | 0.99772436 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 0.99631229 |
| 72 | MP0002933_joint_inflammation | 0.99212429 |
| 73 | MP0008872_abnormal_physiological_respon | 0.98961064 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.97796630 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.97796144 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.97069896 |
| 77 | MP0009697_abnormal_copulation | 0.96858289 |
| 78 | MP0005310_abnormal_salivary_gland | 0.96365005 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.96017347 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.95306945 |
| 81 | MP0005166_decreased_susceptibility_to | 0.95215216 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.92922925 |
| 83 | MP0000490_abnormal_crypts_of | 0.92831332 |
| 84 | MP0003638_abnormal_response/metabolism_ | 0.92409016 |
| 85 | MP0004782_abnormal_surfactant_physiolog | 0.92401604 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.92381182 |
| 87 | MP0001764_abnormal_homeostasis | 0.92234537 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.90354554 |
| 89 | MP0005164_abnormal_response_to | 0.89805580 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.88228825 |
| 91 | MP0001666_abnormal_nutrient_absorption | 0.88070482 |
| 92 | MP0005390_skeleton_phenotype | 0.86815265 |
| 93 | MP0001663_abnormal_digestive_system | 0.86799449 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.85457813 |
| 95 | MP0001542_abnormal_bone_strength | 0.84259579 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.83575812 |
| 97 | MP0003828_pulmonary_edema | 0.81735358 |
| 98 | MP0003763_abnormal_thymus_physiology | 0.81629277 |
| 99 | MP0005451_abnormal_body_composition | 0.81028885 |
| 100 | MP0000371_diluted_coat_color | 0.80726810 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.79797217 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.79644242 |
| 103 | MP0001905_abnormal_dopamine_level | 0.79006320 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.78315033 |
| 105 | MP0001968_abnormal_touch/_nociception | 0.77344233 |
| 106 | MP0005165_increased_susceptibility_to | 0.76679702 |
| 107 | MP0001851_eye_inflammation | 0.76285916 |
| 108 | MP0004808_abnormal_hematopoietic_stem | 0.75562215 |
| 109 | MP0005408_hypopigmentation | 0.72612927 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.72532911 |
| 111 | MP0003693_abnormal_embryo_hatching | 0.71834001 |
| 112 | MP0000358_abnormal_cell_content/ | 0.71753670 |
| 113 | MP0000249_abnormal_blood_vessel | 0.70420272 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.69384798 |
| 115 | MP0001881_abnormal_mammary_gland | 0.69251351 |
| 116 | MP0008775_abnormal_heart_ventricle | 0.68842916 |
| 117 | MP0004142_abnormal_muscle_tone | 0.68729952 |
| 118 | MP0002638_abnormal_pupillary_reflex | 0.68308961 |
| 119 | MP0002254_reproductive_system_inflammat | 0.67989410 |
| 120 | MP0002132_abnormal_respiratory_system | 0.67917620 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67243121 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.66343530 |
| 123 | MP0009840_abnormal_foam_cell | 0.66286518 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.65440354 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.65178054 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.64846723 |
| 127 | MP0000598_abnormal_liver_morphology | 0.63226920 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.62500099 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.62358484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.90728308 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.59236305 |
| 3 | Prolonged bleeding time (HP:0003010) | 5.52746235 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.43918772 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.35488683 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.83253523 |
| 7 | Myositis (HP:0100614) | 4.33408984 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.18209720 |
| 9 | Orchitis (HP:0100796) | 4.07753778 |
| 10 | Optic neuritis (HP:0100653) | 4.02285968 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.02285968 |
| 12 | Increased mean platelet volume (HP:0011877) | 3.96712460 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.91770113 |
| 14 | Menorrhagia (HP:0000132) | 3.88679940 |
| 15 | Abnormal platelet volume (HP:0011876) | 3.88145711 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.39784549 |
| 17 | Increased IgM level (HP:0003496) | 3.39438543 |
| 18 | Recurrent skin infections (HP:0001581) | 3.39347881 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.38060893 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.23493208 |
| 21 | Obstructive lung disease (HP:0006536) | 3.21200436 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21200436 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.13177452 |
| 24 | Vasculitis (HP:0002633) | 3.12180716 |
| 25 | Gingivitis (HP:0000230) | 2.96071864 |
| 26 | Encephalitis (HP:0002383) | 2.96031817 |
| 27 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.94887449 |
| 28 | Recurrent fungal infections (HP:0002841) | 2.93688123 |
| 29 | Stomatitis (HP:0010280) | 2.93665901 |
| 30 | Nausea (HP:0002018) | 2.90890322 |
| 31 | Impaired platelet aggregation (HP:0003540) | 2.90325861 |
| 32 | Abnormal platelet function (HP:0011869) | 2.90325861 |
| 33 | Urticaria (HP:0001025) | 2.89074208 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 2.88074168 |
| 35 | Acute encephalopathy (HP:0006846) | 2.83567124 |
| 36 | Poor head control (HP:0002421) | 2.81922146 |
| 37 | Progressive macrocephaly (HP:0004481) | 2.81276811 |
| 38 | Abnormality of lateral ventricle (HP:0030047) | 2.73155691 |
| 39 | Basal ganglia calcification (HP:0002135) | 2.72793325 |
| 40 | Tetraparesis (HP:0002273) | 2.71776427 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.70001171 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.69253363 |
| 43 | Paralysis (HP:0003470) | 2.62976066 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61468366 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.60231429 |
| 46 | Abnormal pupillary function (HP:0007686) | 2.59541409 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.58956123 |
| 48 | Recurrent pneumonia (HP:0006532) | 2.57637477 |
| 49 | Recurrent viral infections (HP:0004429) | 2.56412624 |
| 50 | Petechiae (HP:0000967) | 2.53985855 |
| 51 | Increased CSF lactate (HP:0002490) | 2.52726784 |
| 52 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.51487136 |
| 53 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.51487136 |
| 54 | Thrombocytosis (HP:0001894) | 2.50385981 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.49532030 |
| 56 | Abnormality of alanine metabolism (HP:0010916) | 2.42445059 |
| 57 | Hyperalaninemia (HP:0003348) | 2.42445059 |
| 58 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.42445059 |
| 59 | Anorexia (HP:0002039) | 2.42320485 |
| 60 | Abnormality of T cells (HP:0002843) | 2.41772023 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.41342678 |
| 62 | Leukocytosis (HP:0001974) | 2.40932866 |
| 63 | IgG deficiency (HP:0004315) | 2.40584576 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.40253427 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.38702727 |
| 66 | Periodontitis (HP:0000704) | 2.38215371 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.36842317 |
| 68 | Exertional dyspnea (HP:0002875) | 2.32942271 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31679385 |
| 70 | Hemoptysis (HP:0002105) | 2.31486321 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.31444037 |
| 72 | Dyschromatopsia (HP:0007641) | 2.31378385 |
| 73 | Neoplasm of head and neck (HP:0012288) | 2.29838119 |
| 74 | Esophageal neoplasm (HP:0100751) | 2.29838119 |
| 75 | Increased serum ferritin (HP:0003281) | 2.28425871 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.28105489 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.28105489 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.27115110 |
| 79 | Arterial thrombosis (HP:0004420) | 2.26069918 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24933285 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24933285 |
| 82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24933285 |
| 83 | Meningitis (HP:0001287) | 2.24734566 |
| 84 | Increased cerebral lipofuscin (HP:0011813) | 2.23868518 |
| 85 | Episodic fever (HP:0001954) | 2.19689223 |
| 86 | Abnormality of the pericardium (HP:0001697) | 2.19210963 |
| 87 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18908297 |
| 88 | Pustule (HP:0200039) | 2.18090023 |
| 89 | Eosinophilia (HP:0001880) | 2.17716941 |
| 90 | Aplastic anemia (HP:0001915) | 2.16602325 |
| 91 | Gingival bleeding (HP:0000225) | 2.16218429 |
| 92 | Albinism (HP:0001022) | 2.11960171 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.11648574 |
| 94 | Abnormality of T cell number (HP:0011839) | 2.08674972 |
| 95 | Abnormality of the pleura (HP:0002103) | 2.08534171 |
| 96 | Joint swelling (HP:0001386) | 2.04877963 |
| 97 | Granulocytopenia (HP:0001913) | 2.03833682 |
| 98 | Increased hepatocellular lipid droplets (HP:0006565) | 2.02692786 |
| 99 | Peritonitis (HP:0002586) | 2.02447122 |
| 100 | Poikilocytosis (HP:0004447) | 2.01733700 |
| 101 | Irregular epiphyses (HP:0010582) | 2.01478221 |
| 102 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01129050 |
| 103 | Reduced antithrombin III activity (HP:0001976) | 2.01080987 |
| 104 | Osteomyelitis (HP:0002754) | 1.99866641 |
| 105 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99713872 |
| 106 | Premature loss of primary teeth (HP:0006323) | 1.97832101 |
| 107 | Prolonged neonatal jaundice (HP:0006579) | 1.97327632 |
| 108 | 3-Methylglutaconic aciduria (HP:0003535) | 1.97159609 |
| 109 | Lactic acidosis (HP:0003128) | 1.96880062 |
| 110 | Cerebral edema (HP:0002181) | 1.95197261 |
| 111 | Arthropathy (HP:0003040) | 1.95163503 |
| 112 | Posterior subcapsular cataract (HP:0007787) | 1.95126967 |
| 113 | Purpura (HP:0000979) | 1.94292005 |
| 114 | Myocardial infarction (HP:0001658) | 1.93666361 |
| 115 | Epistaxis (HP:0000421) | 1.93325361 |
| 116 | Axonal loss (HP:0003447) | 1.93235638 |
| 117 | Gangrene (HP:0100758) | 1.92871508 |
| 118 | Severe visual impairment (HP:0001141) | 1.91307025 |
| 119 | Cellulitis (HP:0100658) | 1.91046503 |
| 120 | Chronic otitis media (HP:0000389) | 1.90103208 |
| 121 | Acute hepatic failure (HP:0006554) | 1.89563222 |
| 122 | Arthralgia (HP:0002829) | 1.89347499 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.88490122 |
| 124 | Dicarboxylic aciduria (HP:0003215) | 1.88353927 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88353927 |
| 126 | Hepatic necrosis (HP:0002605) | 1.87634890 |
| 127 | Mitochondrial inheritance (HP:0001427) | 1.87416009 |
| 128 | Lipid accumulation in hepatocytes (HP:0006561) | 1.87359290 |
| 129 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.85995350 |
| 130 | Severe combined immunodeficiency (HP:0004430) | 1.85355492 |
| 131 | Panhypogammaglobulinemia (HP:0003139) | 1.84806688 |
| 132 | Abnormality of the prostate (HP:0008775) | 1.84184862 |
| 133 | Joint hemorrhage (HP:0005261) | 1.84103251 |
| 134 | Hypoproteinemia (HP:0003075) | 1.83566791 |
| 135 | Increased muscle lipid content (HP:0009058) | 1.82085890 |
| 136 | Tinnitus (HP:0000360) | 1.81507173 |
| 137 | Conjunctival telangiectasia (HP:0000524) | 1.81477719 |
| 138 | Renal Fanconi syndrome (HP:0001994) | 1.80778829 |
| 139 | Polyneuropathy (HP:0001271) | 1.80721871 |
| 140 | Renal cortical cysts (HP:0000803) | 1.79435047 |
| 141 | Dysostosis multiplex (HP:0000943) | 1.79338989 |
| 142 | Abnormality of eosinophils (HP:0001879) | 1.79295815 |
| 143 | Hepatocellular necrosis (HP:0001404) | 1.78886475 |
| 144 | Amyloidosis (HP:0011034) | 1.78463467 |
| 145 | Progressive neurologic deterioration (HP:0002344) | 1.77691058 |
| 146 | Pathologic fracture (HP:0002756) | 1.77686076 |
| 147 | T lymphocytopenia (HP:0005403) | 1.74875392 |
| 148 | Cutaneous photosensitivity (HP:0000992) | 1.72065841 |
| 149 | Cerebral palsy (HP:0100021) | 1.70050270 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70026838 |
| 151 | Abnormality of T cell physiology (HP:0011840) | 1.69224636 |
| 152 | Thick nail (HP:0001805) | 1.69205569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.31682973 |
| 2 | IRAK3 | 3.57210287 |
| 3 | MAP4K2 | 3.48444851 |
| 4 | PBK | 3.41953982 |
| 5 | TBK1 | 3.40331627 |
| 6 | NME2 | 2.90756818 |
| 7 | EIF2AK1 | 2.85030378 |
| 8 | PIM2 | 2.78309552 |
| 9 | IRAK4 | 2.72462260 |
| 10 | RIPK4 | 2.65368659 |
| 11 | BLK | 2.62619708 |
| 12 | IKBKE | 2.49239104 |
| 13 | IKBKB | 2.42287492 |
| 14 | TXK | 2.25256619 |
| 15 | TYK2 | 2.11826360 |
| 16 | JAK3 | 2.06890814 |
| 17 | SIK3 | 1.96373803 |
| 18 | MST4 | 1.71718172 |
| 19 | EIF2AK2 | 1.68072676 |
| 20 | TESK1 | 1.62438175 |
| 21 | NEK9 | 1.57399595 |
| 22 | MAP4K1 | 1.54109256 |
| 23 | ABL2 | 1.51849123 |
| 24 | TNK2 | 1.48068577 |
| 25 | ACVR1B | 1.47659883 |
| 26 | FES | 1.45866058 |
| 27 | ZAP70 | 1.44913819 |
| 28 | RPS6KA4 | 1.44875019 |
| 29 | ITK | 1.43030037 |
| 30 | ERN1 | 1.41554080 |
| 31 | CHUK | 1.41180128 |
| 32 | STK16 | 1.40537064 |
| 33 | EIF2AK3 | 1.38120150 |
| 34 | ARAF | 1.35458845 |
| 35 | NUAK1 | 1.32988542 |
| 36 | BCKDK | 1.29805028 |
| 37 | BMPR2 | 1.26961784 |
| 38 | MAP2K3 | 1.26595062 |
| 39 | KIT | 1.26238885 |
| 40 | BMPR1B | 1.24798102 |
| 41 | YES1 | 1.23025014 |
| 42 | MAPKAPK3 | 1.20400499 |
| 43 | MAP3K12 | 1.20152574 |
| 44 | MAP3K11 | 1.17583873 |
| 45 | ILK | 1.13748163 |
| 46 | GRK5 | 1.11968939 |
| 47 | JAK1 | 1.11429371 |
| 48 | FGR | 1.08084730 |
| 49 | TEC | 1.06921674 |
| 50 | CDK19 | 1.05169402 |
| 51 | GRK1 | 1.03822782 |
| 52 | STK4 | 1.01480489 |
| 53 | ERBB3 | 1.00826131 |
| 54 | PTK2B | 0.99689628 |
| 55 | PIM1 | 0.99389135 |
| 56 | SYK | 0.98469370 |
| 57 | TLK1 | 0.97150938 |
| 58 | GRK6 | 0.96932037 |
| 59 | MAP3K3 | 0.95471186 |
| 60 | BUB1 | 0.90910183 |
| 61 | PRKCQ | 0.88220662 |
| 62 | PIK3CG | 0.86644902 |
| 63 | ADRBK2 | 0.84544397 |
| 64 | PLK4 | 0.83798067 |
| 65 | PAK1 | 0.81977486 |
| 66 | BTK | 0.81854041 |
| 67 | SRPK1 | 0.81792507 |
| 68 | TRIM28 | 0.80708767 |
| 69 | TGFBR2 | 0.79302496 |
| 70 | CSF1R | 0.77837411 |
| 71 | PINK1 | 0.77547356 |
| 72 | IRAK1 | 0.76162551 |
| 73 | MAP3K5 | 0.75353630 |
| 74 | LYN | 0.75111760 |
| 75 | LCK | 0.71380503 |
| 76 | MARK3 | 0.71070085 |
| 77 | TRPM7 | 0.68694613 |
| 78 | KDR | 0.68426178 |
| 79 | PRKCD | 0.68166993 |
| 80 | STK24 | 0.67426567 |
| 81 | CAMKK2 | 0.62972647 |
| 82 | LIMK1 | 0.61042647 |
| 83 | DAPK1 | 0.60474573 |
| 84 | FLT3 | 0.58912312 |
| 85 | PRKG2 | 0.57725388 |
| 86 | ADRBK1 | 0.57705004 |
| 87 | ZAK | 0.56943566 |
| 88 | BRSK2 | 0.56176708 |
| 89 | TAOK3 | 0.55581237 |
| 90 | JAK2 | 0.54755724 |
| 91 | MYLK | 0.54739981 |
| 92 | GRK7 | 0.54539587 |
| 93 | NLK | 0.54236107 |
| 94 | TAOK2 | 0.54009854 |
| 95 | MOS | 0.53577805 |
| 96 | FGFR3 | 0.52623044 |
| 97 | DAPK2 | 0.52363841 |
| 98 | MAPKAPK2 | 0.52094289 |
| 99 | TAOK1 | 0.51775571 |
| 100 | EPHA2 | 0.51701540 |
| 101 | MST1R | 0.51422964 |
| 102 | BCR | 0.50416444 |
| 103 | CDK8 | 0.50365324 |
| 104 | MAP3K13 | 0.47788352 |
| 105 | RPS6KA5 | 0.46260483 |
| 106 | TIE1 | 0.45806640 |
| 107 | PDK2 | 0.45729338 |
| 108 | IGF1R | 0.44190838 |
| 109 | BRAF | 0.43991622 |
| 110 | HCK | 0.43262452 |
| 111 | WNK4 | 0.43210751 |
| 112 | CSK | 0.42133786 |
| 113 | VRK1 | 0.41891901 |
| 114 | PLK2 | 0.41213677 |
| 115 | EPHA3 | 0.40564116 |
| 116 | MAP2K6 | 0.39810474 |
| 117 | STK10 | 0.39410404 |
| 118 | WEE1 | 0.37787058 |
| 119 | ABL1 | 0.37081609 |
| 120 | CSNK1G3 | 0.36177974 |
| 121 | OBSCN | 0.36032739 |
| 122 | DAPK3 | 0.34107350 |
| 123 | IRAK2 | 0.34066684 |
| 124 | PAK4 | 0.34063210 |
| 125 | TGFBR1 | 0.34031130 |
| 126 | MUSK | 0.33690292 |
| 127 | TESK2 | 0.32481978 |
| 128 | BMX | 0.31691073 |
| 129 | MATK | 0.31295873 |
| 130 | DYRK3 | 0.31056468 |
| 131 | PDK1 | 0.30089228 |
| 132 | FGFR4 | 0.29601386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.74367804 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.34085764 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.29714903 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.97412406 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89914647 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.89223304 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.69248892 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.47749375 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.42185065 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31775922 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.20609000 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13562057 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.05052772 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.00002403 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.97100954 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.95470764 |
| 17 | Platelet activation_Homo sapiens_hsa04611 | 1.94548586 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92703671 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.81946075 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76104929 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73026982 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.70627494 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62325784 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.60018699 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.59218723 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58448734 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.51735326 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.50692382 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45853278 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.44418028 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.40713035 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38173359 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.36749219 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28338847 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26730678 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.25381161 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25065965 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.18955210 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17832053 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.17283408 |
| 41 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15947042 |
| 42 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13563234 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11938567 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10303851 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10029984 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09514088 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.06975638 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.01096222 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99463856 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97252507 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96036954 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95890761 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95160646 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93766081 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92052063 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91682391 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90844545 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90462535 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88550050 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.83823992 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.81472381 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80132272 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79949725 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.78512569 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.77335310 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74962689 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74860190 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.70955415 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67333732 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65363978 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.64329945 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63819245 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63268494 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61760976 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60227156 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.59149217 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.58922415 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58543114 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57718223 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.57502342 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57212607 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56291157 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55999675 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54396914 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52367478 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51209682 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50504020 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50380763 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50208347 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50156087 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.47178917 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47163048 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44553071 |
| 94 | Mismatch repair_Homo sapiens_hsa03430 | 0.44200297 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43245918 |
| 96 | Base excision repair_Homo sapiens_hsa03410 | 0.42055829 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41870567 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39612800 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38855634 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.38333980 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38193378 |
| 102 | Homologous recombination_Homo sapiens_hsa03440 | 0.38191540 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37368781 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35167969 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34723639 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33677236 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33142245 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32678520 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32390012 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.32020960 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31790177 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31001623 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30478961 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30075657 |
| 115 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.28470641 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28215385 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27763573 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27038599 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26912622 |
| 120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26507058 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26491588 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26221171 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.25837170 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25387732 |
| 125 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.24905552 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24576203 |

